RE:News...payment rec'dUnfortunately, thats it for milestones. The next payment is due upon completion of phase 3 trial for $1.5MM. That will take at least a couple years at this pace. The phase 1 and 2 pharmacokinetics, safety, tolerability and dose ranging studies will take a while to complete. As bright as it appears, when I attended the AGM this $500 K was fully expected in their 2018 financial statements and is nothing new, as it is merely another step in a deal that was signed 5 years ago. The milestone may pay the retroactive bills for the quarter but its not enough for anything more. Howie needs to bring in new money for a new deal, one deal five years ago is obviously not enough to keep an sufficient operating cash flow.